FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045828185> ?p ?o ?g. }

• W2045828185 endingPage "64" @default.
• W2045828185 startingPage "57" @default.
• W2045828185 abstract "We have studied the feasibility and efficacy of intensified R-MegaCHOP-ESHAP-BEAM therapy in high-risk aggressive B-cell lymphomas. Altogether 105 patients (19–64 years) with diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBL) or follicular lymphoma grade 3 (FL3) with an age-adjusted International Prognostic Index of 2–3 were recruited. Treatment consisted of three cycles of high-dose R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone), followed by three cycles of R-ESHAP (rituximab, etoposide, methylprednisolone, cytarabine, cisplatin) and high-dose consolidation with BEAM (BCNU, etoposide, cytarabine, melphalan) and autologous stem cell transplant. The 5-year progression-free survival (PFS) was 72% (DLBCL 60%, PMBL 89%) and overall survival (OS) was 74% (DLBCL 61%, PMBL 89%) after a median follow-up of 85 months. However, an independent prognostic factor was age only, with patients ≤ 45 years having 5-year PFS 90% and patients > 45 years having PFS 54%. PMBL had better prognosis than DLBCL/FL3 in patients > 45 years (PFS, 88% vs. 48%), but not in younger patients (PFS, 91% vs. 94%)." @default.
• W2045828185 created "2016-06-24" @default.
• W2045828185 creator A5004280549 @default.
• W2045828185 creator A5008998843 @default.
• W2045828185 creator A5015100866 @default.
• W2045828185 creator A5018246293 @default.
• W2045828185 creator A5021274308 @default.
• W2045828185 creator A5022794173 @default.
• W2045828185 creator A5030288033 @default.
• W2045828185 creator A5032636538 @default.
• W2045828185 creator A5034008882 @default.
• W2045828185 creator A5060677002 @default.
• W2045828185 creator A5064830159 @default.
• W2045828185 creator A5076581809 @default.
• W2045828185 creator A5077544452 @default.
• W2045828185 creator A5085568642 @default.
• W2045828185 creator A5088476247 @default.
• W2045828185 date "2014-04-29" @default.
• W2045828185 modified "2023-10-18" @default.
• W2045828185 title "Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial" @default.
• W2045828185 cites W1901906174 @default.
• W2045828185 cites W1960823558 @default.
• W2045828185 cites W2001196047 @default.
• W2045828185 cites W2006709900 @default.
• W2045828185 cites W2035125470 @default.
• W2045828185 cites W2042137630 @default.
• W2045828185 cites W2058015212 @default.
• W2045828185 cites W2072351874 @default.
• W2045828185 cites W2076509494 @default.
• W2045828185 cites W2093090261 @default.
• W2045828185 cites W2095891194 @default.
• W2045828185 cites W2100090512 @default.
• W2045828185 cites W2102311782 @default.
• W2045828185 cites W2106928992 @default.
• W2045828185 cites W2111500154 @default.
• W2045828185 cites W2111827890 @default.
• W2045828185 cites W2125523937 @default.
• W2045828185 cites W2126779872 @default.
• W2045828185 cites W2127682234 @default.
• W2045828185 cites W2137691920 @default.
• W2045828185 cites W2145304413 @default.
• W2045828185 cites W2166157350 @default.
• W2045828185 cites W2166900358 @default.
• W2045828185 cites W2168446621 @default.
• W2045828185 cites W2168681651 @default.
• W2045828185 doi "https://doi.org/10.3109/10428194.2014.904509" @default.
• W2045828185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24628294" @default.
• W2045828185 hasPublicationYear "2014" @default.
• W2045828185 type Work @default.
• W2045828185 sameAs 2045828185 @default.
• W2045828185 citedByCount "2" @default.
• W2045828185 countsByYear W20458281852015 @default.
• W2045828185 countsByYear W20458281852021 @default.
• W2045828185 crossrefType "journal-article" @default.
• W2045828185 hasAuthorship W2045828185A5004280549 @default.
• W2045828185 hasAuthorship W2045828185A5008998843 @default.
• W2045828185 hasAuthorship W2045828185A5015100866 @default.
• W2045828185 hasAuthorship W2045828185A5018246293 @default.
• W2045828185 hasAuthorship W2045828185A5021274308 @default.
• W2045828185 hasAuthorship W2045828185A5022794173 @default.
• W2045828185 hasAuthorship W2045828185A5030288033 @default.
• W2045828185 hasAuthorship W2045828185A5032636538 @default.
• W2045828185 hasAuthorship W2045828185A5034008882 @default.
• W2045828185 hasAuthorship W2045828185A5060677002 @default.
• W2045828185 hasAuthorship W2045828185A5064830159 @default.
• W2045828185 hasAuthorship W2045828185A5076581809 @default.
• W2045828185 hasAuthorship W2045828185A5077544452 @default.
• W2045828185 hasAuthorship W2045828185A5085568642 @default.
• W2045828185 hasAuthorship W2045828185A5088476247 @default.
• W2045828185 hasConcept C126322002 @default.
• W2045828185 hasConcept C143998085 @default.
• W2045828185 hasConcept C2776694085 @default.
• W2045828185 hasConcept C2776755627 @default.
• W2045828185 hasConcept C2778041864 @default.
• W2045828185 hasConcept C2778119113 @default.
• W2045828185 hasConcept C2778476033 @default.
• W2045828185 hasConcept C2778559949 @default.
• W2045828185 hasConcept C2778684742 @default.
• W2045828185 hasConcept C2779338263 @default.
• W2045828185 hasConcept C2779429289 @default.
• W2045828185 hasConcept C2780653079 @default.
• W2045828185 hasConcept C2781214270 @default.
• W2045828185 hasConcept C71924100 @default.
• W2045828185 hasConcept C90924648 @default.
• W2045828185 hasConceptScore W2045828185C126322002 @default.
• W2045828185 hasConceptScore W2045828185C143998085 @default.
• W2045828185 hasConceptScore W2045828185C2776694085 @default.
• W2045828185 hasConceptScore W2045828185C2776755627 @default.
• W2045828185 hasConceptScore W2045828185C2778041864 @default.
• W2045828185 hasConceptScore W2045828185C2778119113 @default.
• W2045828185 hasConceptScore W2045828185C2778476033 @default.
• W2045828185 hasConceptScore W2045828185C2778559949 @default.
• W2045828185 hasConceptScore W2045828185C2778684742 @default.
• W2045828185 hasConceptScore W2045828185C2779338263 @default.
• W2045828185 hasConceptScore W2045828185C2779429289 @default.
• W2045828185 hasConceptScore W2045828185C2780653079 @default.
• W2045828185 hasConceptScore W2045828185C2781214270 @default.
• W2045828185 hasConceptScore W2045828185C71924100 @default.

• next